Kimberly E. Vanover - Net Worth and Insider Trading
Kimberly E. Vanover Net Worth
The estimated net worth of Kimberly E. Vanover is at least $2 Million dollars as of 2024-12-15. Kimberly E. Vanover is the SVP, Early Stage Clinical Dev. of Intra-Cellular Therapies Inc and owns about 27,068 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $2 Million. Details can be seen in Kimberly E. Vanover's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kimberly E. Vanover has not made any transactions after 2019-01-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kimberly E. Vanover
Kimberly E. Vanover Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kimberly E. Vanover owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Kimberly E. Vanover’s form 4 insider trades.
Insider Ownership Summary of Kimberly E. Vanover
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2019-01-07 | VP & Clinical Development |
Kimberly E. Vanover Latest Holdings Summary
Kimberly E. Vanover currently owns a total of 1 stock. Kimberly E. Vanover owns 27,068 shares of Intra-Cellular Therapies Inc (ITCI) as of January 7, 2019, with a value of $2 Million.
Latest Holdings of Kimberly E. Vanover
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2019-01-07 | 27,068 | 83.03 | 2,247,456 |
Holding Weightings of Kimberly E. Vanover
Kimberly E. Vanover Form 4 Trading Tracker
According to the SEC Form 4 filings, Kimberly E. Vanover has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 10,156 shares on January 7, 2019, which brought Kimberly E. Vanover around $116,997.
Insider Trading History of Kimberly E. Vanover
- 1
Kimberly E. Vanover Trading Performance
Kimberly E. Vanover Ownership Network
Ownership Network List of Kimberly E. Vanover
Ownership Network Relation of Kimberly E. Vanover
Kimberly E. Vanover Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Kimberly E. Vanover is the VP & Clinical Development of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , SVP and General Counsel Michael Halstead , and EVP & Chief Commercial Officer Mark Neumann .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Kimberly E. Vanover made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 798,809 shares made by Sharon Mates , a net sale of 181,827 shares made by Michael Halstead , and a net sale of 156,651 shares made by Mark Neumann .
In summary, during the past 3 months, insiders sold 144,280 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 144,280 shares. During the past 18 months, 1,361,677 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,361,677 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Kimberly E. Vanover Mailing Address
Above is the net worth, insider trading, and ownership report for Kimberly E. Vanover. You might contact Kimberly E. Vanover via mailing address: C/o Intra-cellular Therapies, Inc., 3960 Broadway, New York Ny 10032.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
